Skip to main content
. 2014 Jun 17;16(5):441–450. doi: 10.1016/j.neo.2014.04.007

Figure 2.

Figure 2

IC261 treatment inhibited TP53−/− tumor growth in vivo. (A) Representative images of xenografts obtained with HCT-116 cells (image for each treatment was the same mouse) in NOD/SCID mice after treatment with either DMSO or IC261. (B) Mean tumor size over the treatment regimen with IC261 and DMSO control (n = 5 for each group, error bars indicate standard error, the notation * indicates P < 0.05).